Transient impact of omalizumab in pollen allergic patients undergoing specific immunotherapy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Transient impact of omalizumab in pollen allergic patients undergoing specific immunotherapy

Published:2013-06-25 Issue:5 Volume:24 Page:427-433
ISSN:0905-6157
Container-title:Pediatric Allergy and Immunology
language:en
Short-container-title:Pediatr Allergy Immunol

Author:

Kopp Matthias Volkmar¹,Hamelmann Eckard²,Bendiks Meike¹,Zielen Stefan³,Kamin Wolfgang⁴,Bergmann Karl-Christian⁵,Klein Christian⁶,Wahn Ulrich⁷,

Affiliation:

1. Klinik für Kinder- und Jugendmedizin; Schwerpunkt Kinderpneumologie & Allergologie; University of Luebeck; Luebeck; Germany

2. Kinderklinik St. Joseph Hospital; Ruhr-University of Bochum; Bochum; Germany

3. Klinik für Kinderheilkunde; University of Frankfurt; Frankfurt; Germany

4. Klinik für Kinder- und Jugendmedizin; Evangelisches Krankenhaus Hamm; Hamm; Germany

5. Allergie-Zentrum-Charité; Berlin; Germany

6. Novartis Pharma GmbH; Nuernberg; Germany

7. Pediatric Allergy and Immunology; Charité Virchow-Klinikum; Berlin; Germany

Publisher

Wiley

Subject

Immunology,Immunology and Allergy,Pediatrics, Perinatology and Child Health

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/pai.12098/fullpdf

Reference17 articles.

1. Targeting IGE with monoclonal antibodies: the future is now;Fahy;Clin Exp Allergy,1998

2. Effect of omalizumab on symptoms of seasonal allergic rhinitis: a randomized controlled trial;Casale;JAMA,2001

3. Efficacy and tolerability of anti-immunoglobulin E therapy with omalizumab in patients with concomitant allergic asthma and persistent allergic rhinitis: SOLAR;Vignola;Allergy,2004

4. Omalizumab, anti-IgE recombinant humanized monoclonal antibody, for the treatment of severe allergic asthma;Busse;J Allergy Clin Immunol,2001

5. Efficacy of combination treatment with anti-IgE plus specific immunotherapy in polysensitized children and adolescents with seasonal allergic rhinitis;Kuehr;J Allergy Clin Immunol,2002

Cited by 67 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and safety of subcutaneous immunotherapy combined with omalizumab in children with dust mite-induced asthma;Journal of Asthma;2024-07

2. Use of omalizumab and allergen-specific immunotherapy for the treatment of respiratory allergic diseases in children and adults;Allergology and Immunology in Paediatrics;2024-06-24

3. The combination of allergen immunotherapy and biologics for inhalant allergies: Exploring the synergy;Annals of Allergy, Asthma & Immunology;2024-06

4. Omalizumab with allergen immunotherapy in respiratory & food allergy;Indian Journal of Tuberculosis;2024-06

5. Future Directions of Allergen Immunotherapy for Allergic Rhinitis: Experts’ Perspective;The Journal of Allergy and Clinical Immunology: In Practice;2024-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3